Previous close | 22.80 |
Open | 23.60 |
Bid | 25.80 x N/A |
Ask | 27.20 x N/A |
Day's range | 23.60 - 23.60 |
52-week range | 16.40 - 54.50 |
Volume | |
Avg. volume | 0 |
Market cap | 2.04B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | -7.17 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PTC Therapeutics ( NASDAQ:PTCT ) First Quarter 2024 Results Key Financial Results Revenue: US$210.1m (down 4.7% from 1Q...
Q1 2024 PTC Therapeutics Inc Earnings Call
Unveiling robust financial performance and strategic expansions in Q1 2024, PTC Therapeutics Inc (PTCT) sets a promising trajectory.